Cytokinetics Financial Statements
Cytokinetics Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Cytokinetics Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 12.4 | 13.6 | 3.1 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (56.4) | (48.9) | (57.1) |
| Diluted EPS (Net Income) | (1.14) | (1.03) | (1.56) |
Cytokinetics Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 5.5 | 71.9 | 3.1 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (8.2) | 56.0 | (10.7) |
| Diluted EPS (Net Income) | (0.14) | 0.98 | (0.21) |
Cytokinetics Stock Quote & Chart
11/09/09 16:00:02 EST •
NASDAQ •
3.28
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Cytokinetics Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.09 | 7.55 | 7.01 |
| Price/Earnings Ratio | 9.35 | 93.46 | 25.51 |
| Price/Book Ratio | 1.77 | 3.48 | 6.74 |
| Price/Cash Flow Ratio | (51.28) | 41.49 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Cytokinetics Financial Ratios
Cytokinetics Competitive Intelligence
| Amgen | Neurocrine Biosciences | PDL BioPharma | |
|---|---|---|---|
| Annual Sales ($ mil.) | 15,003.0 | 4.0 | 294.3 |
| Employees | 16,900 | 125 | 6 |
| Market Cap ($ mil.) | 55,536.4 | 89.0 | 978.8 |
Competitive Landscape
